Hubei Guangji Pharmaceutical Co., Ltd. (000952.SZ)
CNY 5.2
(0.78%)
CNY 5.2
(0.78%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -141.05 Million CNY | -244.49% |
| 2022 | 97.62 Million CNY | -17.41% |
| 2021 | 118.19 Million CNY | 22.06% |
| 2020 | 96.83 Million CNY | -29.3% |
| 2019 | 136.96 Million CNY | -35.13% |
| 2018 | 211.14 Million CNY | 56.06% |
| 2017 | 135.29 Million CNY | -15.01% |
| 2016 | 159.18 Million CNY | 626.2% |
| 2015 | 21.92 Million CNY | 109.68% |
| 2014 | -226.45 Million CNY | -290.02% |
| 2013 | -58.06 Million CNY | 51.09% |
| 2012 | -118.7 Million CNY | -4072.94% |
| 2011 | -2.84 Million CNY | -153.57% |
| 2010 | 5.31 Million CNY | -87.0% |
| 2009 | 40.83 Million CNY | -64.27% |
| 2008 | 114.29 Million CNY | -59.43% |
| 2007 | 281.74 Million CNY | 733.22% |
| 2006 | 33.81 Million CNY | 85.71% |
| 2005 | 18.2 Million CNY | 38.06% |
| 2004 | 13.18 Million CNY | -26.32% |
| 2003 | 17.89 Million CNY | -34.49% |
| 2002 | 27.32 Million CNY | -15.41% |
| 2001 | 32.29 Million CNY | -12.73% |
| 2000 | 37 Million CNY | 8.25% |
| 1999 | 34.18 Million CNY | 11.15% |
| 1998 | 30.75 Million CNY | -13.7% |
| 1997 | 35.64 Million CNY | 82.79% |
| 1996 | 19.49 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -45.28 Million CNY | 24.36% |
| 2024 Q1 | -56.18 Million CNY | 16.93% |
| 2024 Q2 | -59.87 Million CNY | -6.56% |
| 2023 Q3 | -45.42 Million CNY | -362.51% |
| 2023 Q4 | -67.63 Million CNY | -48.9% |
| 2023 Q1 | -45.29 Million CNY | -206.44% |
| 2023 FY | -141.05 Million CNY | -244.49% |
| 2023 Q2 | 17.3 Million CNY | 138.2% |
| 2022 FY | 97.62 Million CNY | -17.41% |
| 2022 Q4 | 42.55 Million CNY | 865.31% |
| 2022 Q1 | 8.72 Million CNY | -75.52% |
| 2022 Q2 | 18.29 Million CNY | 109.56% |
| 2022 Q3 | -5.56 Million CNY | -130.4% |
| 2021 FY | 118.19 Million CNY | 22.06% |
| 2021 Q1 | 17.89 Million CNY | -31.18% |
| 2021 Q2 | 48.12 Million CNY | 168.92% |
| 2021 Q3 | 16.52 Million CNY | -65.67% |
| 2021 Q4 | 35.65 Million CNY | 115.8% |
| 2020 FY | 96.83 Million CNY | -29.3% |
| 2020 Q4 | 26 Million CNY | -27.34% |
| 2020 Q2 | 48.33 Million CNY | 463.51% |
| 2020 Q3 | 35.79 Million CNY | -25.96% |
| 2020 Q1 | -13.29 Million CNY | 47.6% |
| 2019 Q1 | 37.61 Million CNY | 3.75% |
| 2019 Q3 | 48.41 Million CNY | 26.69% |
| 2019 Q4 | -25.37 Million CNY | -152.42% |
| 2019 FY | 136.96 Million CNY | -35.13% |
| 2019 Q2 | 38.21 Million CNY | 1.58% |
| 2018 Q1 | 116.84 Million CNY | 270.76% |
| 2018 FY | 211.14 Million CNY | 56.06% |
| 2018 Q4 | 36.25 Million CNY | 96.13% |
| 2018 Q3 | 18.48 Million CNY | -53.26% |
| 2018 Q2 | 39.55 Million CNY | -66.15% |
| 2017 Q4 | 31.51 Million CNY | -12.16% |
| 2017 FY | 135.29 Million CNY | -15.01% |
| 2017 Q1 | 32.37 Million CNY | 17.27% |
| 2017 Q2 | 35.53 Million CNY | 9.76% |
| 2017 Q3 | 35.87 Million CNY | 0.97% |
| 2016 Q1 | 25.07 Million CNY | -51.41% |
| 2016 Q2 | 34.62 Million CNY | 38.08% |
| 2016 Q4 | 27.6 Million CNY | -61.6% |
| 2016 FY | 159.18 Million CNY | 626.2% |
| 2016 Q3 | 71.87 Million CNY | 107.55% |
| 2015 Q4 | 51.61 Million CNY | 11514.73% |
| 2015 FY | 21.92 Million CNY | 109.68% |
| 2015 Q3 | 444.38 Thousand CNY | 102.04% |
| 2015 Q2 | -21.81 Million CNY | -162.0% |
| 2015 Q1 | -8.32 Million CNY | 94.26% |
| 2014 FY | -226.45 Million CNY | -290.02% |
| 2014 Q4 | -144.93 Million CNY | -249.96% |
| 2014 Q3 | -41.41 Million CNY | -118.46% |
| 2014 Q2 | -18.95 Million CNY | 10.37% |
| 2014 Q1 | -21.15 Million CNY | -100.86% |
| 2013 FY | -58.06 Million CNY | 51.09% |
| 2013 Q4 | -10.52 Million CNY | -27.95% |
| 2013 Q3 | -8.22 Million CNY | 65.62% |
| 2013 Q2 | -23.93 Million CNY | -55.8% |
| 2013 Q1 | -15.36 Million CNY | 69.74% |
| 2012 FY | -118.7 Million CNY | -4072.94% |
| 2012 Q1 | -14.68 Million CNY | 18.72% |
| 2012 Q3 | -29.76 Million CNY | -26.73% |
| 2012 Q2 | -23.48 Million CNY | -60.01% |
| 2012 Q4 | -50.76 Million CNY | -70.54% |
| 2011 Q2 | 9.25 Million CNY | 131.77% |
| 2011 Q1 | 3.99 Million CNY | 15165.16% |
| 2011 FY | -2.84 Million CNY | -153.57% |
| 2011 Q4 | -18.06 Million CNY | -1018.52% |
| 2011 Q3 | 1.96 Million CNY | -78.76% |
| 2010 Q3 | -3.84 Million CNY | -149.47% |
| 2010 Q4 | 26.16 Thousand CNY | 100.68% |
| 2010 FY | 5.31 Million CNY | -87.0% |
| 2010 Q1 | 1.35 Million CNY | -89.54% |
| 2010 Q2 | 7.77 Million CNY | 474.54% |
| 2009 Q2 | 6.92 Million CNY | 29.47% |
| 2009 Q4 | 12.94 Million CNY | -17.14% |
| 2009 FY | 40.83 Million CNY | -64.27% |
| 2009 Q3 | 15.61 Million CNY | 125.38% |
| 2009 Q1 | 5.35 Million CNY | 152.72% |
| 2008 FY | 114.29 Million CNY | -59.43% |
| 2008 Q4 | -10.15 Million CNY | -156.49% |
| 2008 Q3 | 17.97 Million CNY | -40.64% |
| 2008 Q2 | 30.27 Million CNY | -60.27% |
| 2008 Q1 | 76.2 Million CNY | -36.02% |
| 2007 Q3 | 119.04 Million CNY | 226.67% |
| 2007 Q4 | 119.1 Million CNY | 0.05% |
| 2007 Q2 | 36.44 Million CNY | 409.82% |
| 2007 Q1 | 7.14 Million CNY | -52.41% |
| 2007 FY | 281.74 Million CNY | 733.22% |
| 2006 Q1 | 5.07 Million CNY | -42.62% |
| 2006 Q2 | 5.39 Million CNY | 6.14% |
| 2006 Q3 | 8.32 Million CNY | 54.4% |
| 2006 Q4 | 15.01 Million CNY | 80.44% |
| 2006 FY | 33.81 Million CNY | 85.71% |
| 2005 FY | 18.2 Million CNY | 38.06% |
| 2005 Q2 | 1.2 Million CNY | -66.64% |
| 2005 Q4 | 8.85 Million CNY | 94.52% |
| 2005 Q1 | 3.6 Million CNY | -8.03% |
| 2005 Q3 | 4.55 Million CNY | 278.76% |
| 2004 FY | 13.18 Million CNY | -26.32% |
| 2004 Q4 | 3.91 Million CNY | 70.54% |
| 2004 Q3 | 2.29 Million CNY | -43.17% |
| 2004 Q1 | 2.93 Million CNY | 193.59% |
| 2004 Q2 | 4.04 Million CNY | 37.76% |
| 2003 Q4 | 999.22 Thousand CNY | -75.07% |
| 2003 Q2 | 7.82 Million CNY | 54.38% |
| 2003 FY | 17.89 Million CNY | -34.49% |
| 2003 Q1 | 5.06 Million CNY | 249.21% |
| 2003 Q3 | 4 Million CNY | -48.76% |
| 2002 Q1 | 32.58 Million CNY | 0.0% |
| 2002 Q4 | 1.45 Million CNY | -84.71% |
| 2002 Q3 | 9.49 Million CNY | 194.34% |
| 2002 Q2 | -10.06 Million CNY | -130.88% |
| 2002 FY | 27.32 Million CNY | -15.41% |
| 2001 FY | 32.29 Million CNY | -12.73% |
| 2000 FY | 37 Million CNY | 8.25% |
| 1999 FY | 34.18 Million CNY | 11.15% |
| 1998 FY | 30.75 Million CNY | -13.7% |
| 1997 FY | 35.64 Million CNY | 82.79% |
| 1996 FY | 19.49 Million CNY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 825.98 Million CNY | 117.077% |
| Zhejiang Zhenyuan Share Co., Ltd. | 113.04 Million CNY | 224.781% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | -104.37 Million CNY | -35.135% |
| Yifan Pharmaceutical Co., Ltd. | -882.71 Million CNY | 84.02% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 40.51 Million CNY | 448.146% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 3.65 Billion CNY | 103.86% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | -56.7 Million CNY | -148.742% |
| Boai NKY Medical Holdings Ltd. | 585.23 Million CNY | 124.102% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 344.97 Million CNY | 140.888% |